HopeStage
Back to all studies
CompletedNCT01164059

Comparing Older and Newer Antipsychotic Treatment Strategies

About this titleRead the official source — NCT01164059

This study evaluated the effectiveness of Olanzapine for people with schizophrenia.

Medication studyAges 18–65Germany
The study in practice

Understand this study

What did researchers investigate?

This study evaluated the effectiveness of Olanzapine for people with schizophrenia.

Who was this study for?

This study was for people with schizophrenia. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.

Listed locations
Aachen and 17 more locationsSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateFebruary 2010
Recruitment status
Completed
Enrollment listed in the registry
149
Sponsor
University of Bremen
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
Germany
Age range
From 18 Years to 65 Years
Official registry ID
NCT01164059
Official title
Show the full official title

Clinical Effectiveness Of The Newer Antipsychotic Compounds Olanzapine, Quetiapine And Aripiprazole In Comparison With Low Dose Conventional Antipsychotics (Haloperidol And Flupentixol) In Patients With Schizophrenia

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Aachen · Angermünde · Bad Zwischenahn

14 more locations
  • Berlin
  • Bochum
  • Bremen
  • Düsseldorf
  • Eisenhüttenstadt
  • Göttingen
  • Hamburg
  • Hanover
  • Liebenburg
  • Neubrandenburg
  • Neuruppin
  • Potsdam
  • Rüdersdorf
  • Taufkirchen

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

What did researchers investigate?

This study evaluated the effectiveness of Olanzapine for people with schizophrenia.

Who is behind this study?

The study sponsor is University of Bremen, a university.

Did this study involve medication?

Yes. The study involved medication, including Olanzapine, Flupentixol, Quetiapine, Aripiprazole and Haloperidol.

Who was this study for?

This study was for people with schizophrenia. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.

Want to explore more studies?

Explore studies